Siplizumab
Product Specifications
CAS Number
288392-69-8
Target
Immunology/Inflammation related|||Others
Related Pathways
Immunology/Inflammation|||Others
Purity
1
Bioactivity
Siplizumab (MEDI-507) is a humanized IgG1 monoclonal antibody that targets CD2, selectively depleting effector memory T cells and promoting the relative expansion of alloreactive regulatory T cells in vitro. Siplizumab can be used to treat plaque psoriasis.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1369075-01 0.02 mg (E-Coli)
Recombinant Acanthamoeba polyphaga mimivirus Uncharacterized protein L662 (MIMI_L662)
Ask
View Details 
MBS1369075-02 0.02 mg (Yeast)
Recombinant Acanthamoeba polyphaga mimivirus Uncharacterized protein L662 (MIMI_L662)
Ask
View Details 
MBS1369075-03 0.1 mg (E-Coli)
Recombinant Acanthamoeba polyphaga mimivirus Uncharacterized protein L662 (MIMI_L662)
Ask
View Details MBS1369075-04 0.1 mg (Yeast)
Recombinant Acanthamoeba polyphaga mimivirus Uncharacterized protein L662 (MIMI_L662)
Ask
View Details MBS1369075-05 0.02 mg (Baculovirus)
Recombinant Acanthamoeba polyphaga mimivirus Uncharacterized protein L662 (MIMI_L662)
Ask
View Details MBS1369075-06 0.02 mg (Mammalian-Cell)
Recombinant Acanthamoeba polyphaga mimivirus Uncharacterized protein L662 (MIMI_L662)
Ask
View Details